If you are having trouble viewing this email, please click here.
Axtria Collective Banner Feb 24 Final-01

Welcome to the Axtria Collective!

This edition honors Rare Disease Day 2024, a global campaign that aims to raise awareness and support for people living with rare diseases.

Learn why a data-first approach is crucial for rare disease treatments, discover the main challenges for rare disease sales teams, and listen to a podcast on the importance of AI and patient voice in pharma R&D. Plus, access our latest report on the critical trends in pharma promotional effectiveness and read how MLOps is revolutionizing pharma.

Happy reading!


Featured-Content-Banner (1)

Unlocking Promotional Success: Insights from 140+ Marketing Mix Studies

To stay ahead of the curve in pharma marketing, you need to know what strategy works for the industry. This report draws insights from over 140 marketing mix studies and reveals the key trends and recommendations for pharma promotional effectiveness. Discover the trajectory of digital spending, the impact of diverse digital channels on customer engagement, and how to align your marketing objectives with patient needs.

Download Your Copy



To Fight Rare Diseases, Win the Data Battle First

Jassi Chadha, CEO & President of Axtria, discusses how data-driven approaches and AI can enable pharmaceutical companies to accelerate the development and adoption of innovative therapies for rare diseases. Discover how data can make a difference in the fight against rare diseases.

Read More



The Importance of AI and Patient Voice in Pharma R&D

Gurdyal Kalsi is a physician-scientist and leader in innovative therapies for rare and complex diseases. Listen to him discuss the art and science of AI in healthcare, the significance of giving patients a voice in clinical trials, and the necessity of striving for a definitive cure rather than symptomatic treatment.

Listen Now

IC_Infographic_Alignment Design_PDF_2024-1



Reshaping Pharma’s Commercial Horizon with MLOps

The synergy of data, artificial intelligence, and machine learning operations (MLOps) is driving the pharma industry toward an age of unparalleled innovation. This article outlines the possibilities of MLOps, how MLOps promotes inclusivity, and how it becomes a catalyst for commercial agility.

Read More


Top 5 Sales Challenges For Rare Disease Teams

This article covers the top five challenges faced by rare disease pharmaceutical companies in the end-to-end commercialization process, from sales crediting to incentivizing field sales personnel. It also explores how cloud-based product suites can mitigate these challenges.

Read More


PMSA 2024 Global Summit

Axtria is a Gold Sponsor for the Pharmaceutical Management Science Association (PMSA) 2024 Global Summit, which will be conducted on March 7-8, 2024, in New Delhi, India. The ability to transform patient lives, scale analytics models, strengthen operational frameworks, and infuse Gen AI in the day-to-day will form the key themes of PMSA and Axtria's partnership at the summit.

Learn More


Axtria Once Again Recognized with Great Place To Work® Certification™

This marks Axtria’s sixth consecutive year of GPTW certification in India and fourth consecutive year in the United States. This achievement is a tribute to all Axtrians contributing to our success and celebrating united efforts. Read More>>

Elevate 2024: Axtria's Leaders Meet

Recently, Axtria leaders from across India converged in Goa for Elevate 2024, a three-day offsite event full of networking, learning, and collaboration. The event had engaging sessions, fun activities, and memorable moments that will inspire and empower our company for 2024 and beyond. Check out the pictures>>

Axtria Careers-1
Group 53471